Navigation Links
Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer
Date:9/26/2011

improve patient outcomes.

Ipsen will be responsible for marketing and selling Hexvix worldwide, excluding the US and Nordic region. Ipsen has a strong and well established uro-oncology franchise and will commercialise Hexvix through its dedicated urology salesforce. Photocure retains the rights to the product in the Nordics and the US.  

Photocure will receive an upfront payment of EUR 6.5 million related to the successful completion of transition milestones, as well as double digit royalties on all sales and milestones on specific sales achievements.  In addition, Photocure will manufacture the product for Ipsen. In 2012 and 2013 Photocure will invest with Ipsen in marketing and sales programs to drive momentum and accelerate the sales growth of Hexvix. Detailed financial terms were not disclosed but are in line with standard industry agreements for a marketed product.

In the US, Photocure will commercialise Cysview through establishing its own operations. The target market in the US is concentrated and can be addressed with a niche salesforce. Photocure will leverage its knowledge and expertise in marketing and selling Hexvix in the Nordics where it has achieved greater than 30% market share, to maximise the potential of Cysview in the US market. Timing of launch is anticipated during the first quarter of 2012.

Kjetil Hestdal, President & CEO of Photocure, said:

"We are delighted to announce a new and focused commercial platform for our Hexvix brand. Our strategy is to build Photocure into a profitable specialty pharmaceutical company by maximising the potential of our products.  This is a major step forward in executing our strategy. Ipsen is an excellent partner with its strategic focus on uro-oncology and a dedicated salesforce. We believe this agreement, combined with establishing our own commercial operations in the US, will maximise the potential of Hexvix/Cysview and provide long term value for our shar
'/>"/>

SOURCE Photocure ASA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... -- SeraCare Life Sciences, a leading partner to global ... AACC Annual Meeting today that it has signed ... biotechnology company that develops, markets and sells preanalytic ... ViveST™ allow sample collection, transport and storage in ... of the agreement, the two firms will jointly ...
(Date:7/27/2015)... July 27, 2015  The fairness of the proposed ... St. Jude Medical ("St. Jude") is the subject of ... shareholder rights law firm.  The investigation is focusing on ... law by the Board of Directors of THOR for ... July 22, 2015, the Company announced it had reached a ...
(Date:7/27/2015)... , July 20, 2015 ... has announced the addition of the "Cardiometabolic ... Afrezza,s discounted pricing is in line ... is critical to the product,s commercial appeal. However, ... prevent Afrezza from gaining a sizeable share of ...
Breaking Medicine Technology:SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 2SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 3WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3
... Motion Therapeutics, Inc. http://www.motiontherapeutics.com , the leading provider ... today announced that researchers at Samuel Merritt University and ... to study the effects of wearing a strategically weighted ... MS. This grant comes after the ...
... Argon Medical Devices, Inc. announced today that it ... LP ("Rex Medical") for exclusive global rights to market and ... device used in the prevention of Pulmonary Embolism (PE). ... to our product portfolio. This proven technology has rapidly become ...
Cached Medicine Technology:The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant 2Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option™ Retrievable Inferior Vena Cava Filter 2Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option™ Retrievable Inferior Vena Cava Filter 3
(Date:7/28/2015)... ... July 28, 2015 , ... ... that Schneider Electric has completed its upgrade and expansion of its ... with more than 170,000 employees in 134 countries supplying a wide range of ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... biologics and biologic-device combination products for the treatment of bone disorders and conditions ... Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new Taiwanese study suggests ... are in the general population. Surviving Mesothelioma has just posted an article detailing ... at Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated the health ...
(Date:7/28/2015)... MA (PRWEB) , ... July 28, 2015 , ... Women ... cancer. One reason is that cancer, heart attack, and stroke are treatable, but there ... thing individuals can do is to take part in a clinical trial, reports the ...
(Date:7/28/2015)... ... July 28, 2015 , ... Every summer, the public is reminded ... caution when lighting fireworks in their own neighborhoods. Unfortunately, according to a recent report ... 3, 2015 USA Today article " Eye Injuries Caused by Fireworks Doubled in Last ...
Breaking Medicine News(10 mins):Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3
... (Jan. 17, 2008) Twenty research projects have been ... at the Argonne Leadership Computing Facility (ALCF) at Argonne ... competitively selected group of 55 scientific projects announced Thursday ... awards are made through the 2008 Innovative and Novel ...
... diagnostic tool to detect surface cancers quickly and ... calculate body composition has been developed by a ... from QUTs School of Physical and Chemical Sciences ... spectroscopy to diagnose cervical and skin cancers. , ...
... stroke and even death, study finds , , FRIDAY, ... to aspirin are four times more likely to suffer a ... says. , People who are aspirin-resistant have platelets -- the ... in the same way as platelets in people who respond ...
... Jan. 18 Cardiac Science,Corporation (Nasdaq: ... cardiac diagnosis,resuscitation, rehabilitation, and informatics products, announced ... its first responder units with,425 Powerheart(R) G3 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ), "Like first ...
... Farm Safety 4 Just Kids Founder, Adams, Reaches Finals of 6th Annual Volvo ... Celebrity Judges Will Select and Unveil Top Four Winners March 19 at Volvo,for life ... ... Life, IRVINE, Calif., Jan. 18 For the past ...
... Jan. 18 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI;,TSX: ... reduction in its,overall headcount affecting approximately 115 people ... U.S. subsidiaries, including members,of its management team., ... undertaken by the,Company as part of its strategic ...
Cached Medicine News:Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 2Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 3Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 4Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 5Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 6Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 7Health News:Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department 2Health News:Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department 3Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 2Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 3Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 4Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 5Health News:QLT reduces workforce as first step in its strategic restructure 2Health News:QLT reduces workforce as first step in its strategic restructure 3
The ultimate ultrasound system for clinical ophthalmologists....
The Ultrasonic BioMicroscope (UBM P40) provides the highest ultrasound resolution for imaging....
EchoScan US-3300 takes accurate axial length and corneal thickness measurements in either automatic or manual modes. It is available in a single configuration or in combination with the A scan for ma...
... eye. Whether used as part of ... independently to accommodate a specific scanning ... to accommodate maximizing the image resolution. ... tonometer-mounted, hand-held and immersion techniques. Unique ...
Medicine Products: